Is Sigachi Indust. overvalued or undervalued?

As of 17 June 2025, the valuation grade for Sigachi Industries has moved from very expensive to expensive. The company appears to be overvalued based on its current metrics. Key ratios include a PE Ratio of 26.28, an EV to EBITDA of 18.77, and a Price to Book Value of 3.04, which suggest that the stock is trading at a premium compared to its earnings and book value.
In comparison to its peers, Sigachi's PE Ratio is lower than Sun Pharma's 34.6 but higher than Cipla's 23.04, indicating a mixed positioning within the industry. Additionally, the PEG Ratio of 1.46 suggests that the stock may not be justified by its growth rate when compared to peers like Dr. Reddy's Labs, which has a more attractive PEG of 14.6. Despite a recent positive return of 23.97% over the past month, the overall valuation suggests that Sigachi Industries is overvalued in the current market context.